Chemours Company (CC) Stock Forecast, Price Target & Predictions
CC Stock Forecast
Chemours Company stock forecast is as follows: an average price target of $30.33 (represents a 58.30% upside from CC’s last price of $19.16) and a rating consensus of 'Buy', based on 14 wall street analysts offering a 1-year stock forecast.
CC Price Target
The average price target for Chemours Company (CC) is $30.33 based on 1-year price targets from 14 Wall Street analysts in the past 3 months, with a price target range of $42.00 to $18.00. This represents a potential 58.30% upside from CC's last price of $19.16.
CC Analyst Ratings
According to 14 Wall Street analysts, Chemours Company's rating consensus is 'Buy'. The analyst rating breakdown for CC stock is 0 'Strong Buy' (0.00%), 10 'Buy' (71.43%), 3 'Hold' (21.43%), 0 'Sell' (0.00%), and 1 'Strong Sell' (7.14%).
Chemours Company Price Target by Analyst
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| Oct 11, 2024 | Arun Viswanathan | RBC Capital | $28.00 | $19.78 | 41.56% | 46.14% |
| Oct 07, 2024 | John McNulty | BMO Capital | $32.00 | $19.57 | 63.52% | 67.01% |
| Aug 06, 2024 | John McNulty | BMO Capital | $30.00 | $18.77 | 59.83% | 56.58% |
| Jun 07, 2024 | John Roberts | Mizuho Securities | $25.00 | $23.90 | 4.60% | 30.48% |
| May 29, 2024 | Rich Hilliker | UBS | $31.00 | $26.65 | 16.32% | 61.80% |
| Apr 09, 2024 | John McNulty | BMO Capital | $34.00 | $27.05 | 25.69% | 77.45% |
| Apr 01, 2024 | Joshua Spector | UBS | $28.00 | $28.74 | -2.57% | 46.14% |
| Apr 01, 2024 | Emily Nassedd Mitsch | CFRA | $18.00 | $28.74 | -37.37% | -6.05% |
| Mar 13, 2024 | Linda Bolton Weiser | D.A. Davidson | $24.00 | $26.84 | -10.58% | 25.26% |
| Dec 01, 2023 | Arun Viswanathan | RBC Capital | $40.00 | $29.53 | 35.46% | 108.77% |
The latest Chemours Company stock forecast, released on Oct 11, 2024 by Arun Viswanathan from RBC Capital, set a price target of $28.00, which represents a 41.56% increase from the stock price at the time of the forecast ($19.78), and a 46.14% increase from CC last price ($19.16).
Chemours Company Price Target by Period
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | - | 2 | 10 |
| Avg Price Target | - | $30.00 | $29.00 |
| Last Closing Price | $19.16 | $19.16 | $19.16 |
| Upside/Downside | -100.00% | 56.58% | 51.36% |
In the current month, the average price target of Chemours Company stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to Chemours Company's last price of $19.16. This month's average price target is down -100.00% compared to last quarter, and down -100.00% compared to last year.
Analyst Ratings Upgrades/Downgrades
| Date | Company | Previous Rating | New Rating | Rating Change |
|---|---|---|---|---|
| Oct 11, 2024 | RBC Capital | Outperform | Outperform | Hold |
| Oct 07, 2024 | BMO Capital | Outperform | Outperform | Hold |
| Sep 11, 2024 | Wells Fargo | Overweight | Overweight | Hold |
| Aug 28, 2024 | BMO Capital | Outperform | Outperform | Hold |
| Aug 28, 2024 | Wells Fargo | Equal-Weight | Underweight | Downgrade |
| Aug 06, 2024 | BMO Capital | Outperform | Outperform | Hold |
| Aug 01, 2024 | Wells Fargo | Equal-Weight | Equal-Weight | Hold |
| May 29, 2024 | UBS | Buy | Buy | Hold |
| Apr 16, 2024 | Deutsche Bank | Buy | Buy | Hold |
| Apr 01, 2024 | UBS | Neutral | Neutral | Hold |
Chemours Company's last stock rating was published by RBC Capital on Oct 11, 2024. The company gave CC a "Outperform" rating, the same as its previous rate.
Chemours Company Financial Forecast
Chemours Company Revenue Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | - | - | - | $1.36B | $1.49B | $1.64B | $1.54B | $1.34B | $1.78B | $1.92B | $1.76B | $1.57B | $1.68B | $1.66B | $1.44B | $1.34B | $1.23B | $1.09B | $1.30B | $1.35B | $1.39B |
| Avg Forecast | $1.60B | $1.73B | $1.77B | $1.60B | $1.48B | $1.58B | $1.59B | $1.41B | $1.37B | $1.44B | $1.53B | $1.35B | $1.32B | $1.51B | $1.68B | $1.46B | $1.27B | $1.67B | $1.84B | $1.57B | $1.57B | $1.58B | $1.53B | $1.40B | $1.28B | $1.20B | $1.09B | $1.33B | $1.35B | $1.37B |
| High Forecast | $1.64B | $1.78B | $1.82B | $1.64B | $1.52B | $1.63B | $1.63B | $1.42B | $1.38B | $1.46B | $1.53B | $1.35B | $1.34B | $1.51B | $1.73B | $1.51B | $1.30B | $1.67B | $1.84B | $1.57B | $1.57B | $1.58B | $1.53B | $1.40B | $1.28B | $1.20B | $1.09B | $1.33B | $1.35B | $1.37B |
| Low Forecast | $1.52B | $1.65B | $1.69B | $1.52B | $1.41B | $1.51B | $1.51B | $1.40B | $1.35B | $1.43B | $1.53B | $1.35B | $1.30B | $1.51B | $1.60B | $1.39B | $1.21B | $1.67B | $1.84B | $1.57B | $1.57B | $1.58B | $1.53B | $1.40B | $1.28B | $1.20B | $1.09B | $1.33B | $1.35B | $1.37B |
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 4 | 2 | 2 | 2 | 4 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 5 | 4 | 5 | 4 | 4 | 3 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 1.03% | 0.98% | 0.98% | 1.05% | 1.06% | 1.06% | 1.04% | 1.12% | 1.00% | 1.06% | 1.08% | 1.03% | 1.04% | 1.03% | 1.01% | 0.98% | 1.00% | 1.02% |
Chemours Company's average Quarter revenue forecast for Mar 24 based on 2 analysts is $1.35B, with a low forecast of $1.35B, and a high forecast of $1.35B. CC's average Quarter revenue forecast represents a -0.85% decrease compared to the company's last Quarter revenue of $1.36B (Dec 23).
Chemours Company EBITDA Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 4 | 2 | 2 | 2 | 4 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 5 | 4 | 5 | 4 | 4 | 3 |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | $-558.00M | $88.00M | $-397.00M | $310.00M | $90.00M | $403.00M | $272.00M | $404.00M | $420.00M | $355.00M | $171.00M | $233.00M | $153.00M | $193.00M | $154.00M | $210.00M | $-323.00M | $222.00M |
| Avg Forecast | $209.86M | $227.85M | $232.98M | $209.81M | $195.11M | $208.10M | $209.04M | $185.13M | $179.90M | $189.65M | $201.21M | $249.73M | $173.10M | $199.01M | $221.12M | $227.03M | $493.86M | $220.27M | $241.60M | $179.47M | $206.21M | $207.84M | $200.81M | $203.41M | $168.45M | $157.95M | $142.96M | $105.46M | $178.05M | $179.65M |
| High Forecast | $215.60M | $234.08M | $239.35M | $215.55M | $200.45M | $213.79M | $214.76M | $186.44M | $181.22M | $191.43M | $201.21M | $299.67M | $175.63M | $199.07M | $227.17M | $272.43M | $592.63M | $220.27M | $241.60M | $215.36M | $206.21M | $207.84M | $200.81M | $244.10M | $168.45M | $157.95M | $142.96M | $126.55M | $178.05M | $179.65M |
| Low Forecast | $199.79M | $216.92M | $221.80M | $199.74M | $185.75M | $198.11M | $199.01M | $183.81M | $177.28M | $187.86M | $201.21M | $199.78M | $170.58M | $198.95M | $210.51M | $181.62M | $395.09M | $220.27M | $241.60M | $143.57M | $206.21M | $207.84M | $200.81M | $162.73M | $168.45M | $157.95M | $142.96M | $84.37M | $178.05M | $179.65M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | -3.22% | 0.44% | -1.80% | 1.37% | 0.18% | 1.83% | 1.13% | 2.25% | 2.04% | 1.71% | 0.85% | 1.15% | 0.91% | 1.22% | 1.08% | 1.99% | -1.81% | 1.24% |
4 analysts predict CC's average Quarter EBITDA for Dec 23 to be $173.10M, with a high of $175.63M and a low of $170.58M. This is 96.71% upper than Chemours Company's previous annual EBITDA (Sep 23) of $88.00M.
Chemours Company Net Income Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 4 | 2 | 2 | 2 | 4 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 5 | 4 | 5 | 4 | 4 | 3 |
| Net Income | - | - | - | - | - | - | - | - | - | - | - | - | $-27.00M | $20.00M | $-376.00M | $145.00M | $-97.00M | $240.00M | $201.00M | $234.00M | $233.00M | $214.00M | $66.00M | $96.00M | $19.00M | $76.00M | $24.00M | $100.00M | $-317.00M | $76.00M |
| Avg Forecast | $112.27M | $152.69M | $179.64M | $122.75M | $75.39M | $106.74M | $108.34M | $66.96M | $21.11M | $42.69M | $85.54M | $147.94M | $40.27M | $103.01M | $161.56M | $134.49M | $273.98M | $156.69M | $211.54M | $106.32M | $133.21M | $150.96M | $141.79M | $83.81M | $63.14M | $49.14M | $15.37M | $50.22M | $62.71M | $86.06M |
| High Forecast | $116.26M | $158.12M | $186.02M | $127.12M | $78.07M | $110.53M | $112.20M | $69.34M | $40.12M | $43.72M | $85.57M | $177.53M | $59.72M | $103.23M | $170.02M | $161.39M | $328.77M | $156.69M | $211.54M | $127.58M | $133.21M | $150.96M | $146.80M | $100.57M | $63.14M | $49.14M | $15.37M | $60.26M | $62.71M | $86.06M |
| Low Forecast | $105.27M | $143.17M | $168.43M | $115.10M | $70.69M | $100.08M | $101.59M | $65.78M | $8.45M | $41.65M | $85.51M | $118.35M | $20.83M | $102.80M | $153.10M | $107.59M | $219.18M | $156.69M | $211.54M | $85.05M | $133.21M | $150.96M | $136.78M | $67.05M | $63.14M | $49.14M | $15.37M | $40.17M | $62.71M | $86.06M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | -0.67% | 0.19% | -2.33% | 1.08% | -0.35% | 1.53% | 0.95% | 2.20% | 1.75% | 1.42% | 0.47% | 1.15% | 0.30% | 1.55% | 1.56% | 1.99% | -5.06% | 0.88% |
Chemours Company's average Quarter net income forecast for Dec 23 is $40.27M, with a range of $20.83M to $59.72M. CC's average Quarter net income forecast represents a 101.37% increase compared to the company's last Quarter net income of $20.00M (Sep 23).
Chemours Company SG&A Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 4 | 2 | 2 | 2 | 4 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 5 | 4 | 5 | 4 | 4 | 3 |
| SG&A | - | - | - | - | - | - | - | - | - | - | - | - | $222.00M | $165.00M | $779.00M | $124.00M | $175.00M | $140.00M | $254.00M | $141.00M | $159.00M | $124.00M | $172.00M | $139.00M | $177.00M | $113.00M | $111.00M | $126.00M | $148.00M | $130.00M |
| Avg Forecast | $196.90M | $213.78M | $218.59M | $196.85M | $183.06M | $195.24M | $196.13M | $173.69M | $168.79M | $177.93M | $188.78M | $89.14M | $162.41M | $186.72M | $207.46M | $81.04M | $186.96M | $206.67M | $226.68M | $64.06M | $193.48M | $195.01M | $188.41M | $121.35M | $158.04M | $148.20M | $134.13M | $63.27M | $167.06M | $168.55M |
| High Forecast | $202.28M | $219.62M | $224.57M | $202.23M | $188.07M | $200.58M | $201.49M | $174.92M | $170.03M | $179.61M | $188.78M | $106.97M | $164.78M | $186.78M | $213.14M | $97.25M | $224.35M | $206.67M | $226.68M | $76.88M | $193.48M | $195.01M | $188.41M | $145.62M | $158.04M | $148.20M | $134.13M | $75.93M | $167.06M | $168.55M |
| Low Forecast | $187.45M | $203.52M | $208.10M | $187.41M | $174.28M | $185.88M | $186.72M | $172.46M | $166.33M | $176.26M | $188.78M | $71.31M | $160.04M | $186.66M | $197.51M | $64.83M | $149.57M | $206.67M | $226.68M | $51.25M | $193.48M | $195.01M | $188.41M | $97.08M | $158.04M | $148.20M | $134.13M | $50.62M | $167.06M | $168.55M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 1.37% | 0.88% | 3.75% | 1.53% | 0.94% | 0.68% | 1.12% | 2.20% | 0.82% | 0.64% | 0.91% | 1.15% | 1.12% | 0.76% | 0.83% | 1.99% | 0.89% | 0.77% |
Chemours Company's average Quarter SG&A projection for Mar 24 is $89.14M, based on 2 Wall Street analysts, with a range of $71.31M to $106.97M. The forecast indicates a -59.85% fall compared to CC last annual SG&A of $222.00M (Dec 23).
Chemours Company EPS Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 4 | 2 | 2 | 2 | 4 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 5 | 4 | 5 | 4 | 4 | 3 |
| EPS | - | - | - | - | - | - | - | - | - | - | - | - | $-0.18 | $0.13 | $-2.52 | $0.97 | $-0.59 | $1.54 | $1.29 | $1.46 | $1.41 | $1.30 | $0.40 | $0.58 | $0.12 | $0.46 | $0.15 | $0.61 | $-1.93 | $0.46 |
| Avg Forecast | $0.75 | $1.02 | $1.20 | $0.82 | $0.50 | $0.71 | $0.72 | $0.45 | $0.14 | $0.29 | $0.57 | $0.18 | $0.27 | $0.69 | $1.08 | $0.46 | $0.10 | $1.04 | $1.41 | $0.91 | $0.89 | $1.01 | $0.94 | $0.63 | $0.42 | $0.33 | $0.10 | $0.46 | $0.42 | $0.57 |
| High Forecast | $0.78 | $1.06 | $1.24 | $0.85 | $0.52 | $0.74 | $0.75 | $0.46 | $0.27 | $0.29 | $0.57 | $0.18 | $0.40 | $0.69 | $1.14 | $0.48 | $0.10 | $1.04 | $1.41 | $0.91 | $0.89 | $1.01 | $0.98 | $0.63 | $0.42 | $0.33 | $0.10 | $0.46 | $0.42 | $0.57 |
| Low Forecast | $0.70 | $0.96 | $1.13 | $0.77 | $0.47 | $0.67 | $0.68 | $0.44 | $0.06 | $0.28 | $0.57 | $0.18 | $0.14 | $0.69 | $1.02 | $0.43 | $0.09 | $1.04 | $1.41 | $0.91 | $0.89 | $1.01 | $0.91 | $0.63 | $0.42 | $0.33 | $0.10 | $0.46 | $0.42 | $0.57 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | -0.67% | 0.19% | -2.33% | 2.11% | -6.14% | 1.48% | 0.92% | 1.60% | 1.59% | 1.29% | 0.42% | 0.91% | 0.27% | 1.41% | 1.47% | 1.32% | -4.62% | 0.80% |
According to 4 Wall Street analysts, Chemours Company's projected average Quarter EPS for Dec 23 is $0.27, with a low estimate of $0.14 and a high estimate of $0.40. This represents a 106.95% increase compared to CC previous annual EPS of $0.13 (Sep 23).
Chemours Company Peer Comparison by Price Target
| Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
|---|---|---|---|---|---|
| OEC | Orion Engineered Carbons | $17.20 | $32.00 | 86.05% | Buy |
| CC | Chemours Company | $19.16 | $30.33 | 58.30% | Buy |
| ASH | Ashland | $77.45 | $115.55 | 49.19% | Buy |
| PPG | PPG Industries | $123.42 | $160.65 | 30.17% | Buy |
| ESI | Element Solutions | $28.51 | $35.88 | 25.85% | Buy |
| WLK | Westlake | $128.26 | $159.67 | 24.49% | Hold |
| IFF | International Flavors & Fragrances | $89.85 | $109.46 | 21.83% | Buy |
| LYB | LyondellBasell Industries | $83.44 | $101.65 | 21.82% | Hold |
| ECVT | Ecovyst | $8.18 | $9.67 | 18.22% | Buy |
| FUL | H.B. Fuller Company | $76.08 | $85.60 | 12.51% | Buy |
| KWR | Quaker Chemical | $171.63 | $192.50 | 12.16% | Buy |
| SXT | Sensient | $79.16 | $85.00 | 7.38% | - |
| WTTR | Select Energy Services | $13.70 | $14.50 | 5.84% | Buy |
| APD | Air Products and Chemicals | $312.89 | $313.43 | 0.17% | Buy |
| CBT | Cabot | $110.95 | $108.67 | -2.05% | Hold |
| AXTA | Axalta Coating Systems | $40.60 | $38.25 | -5.79% | Buy |
| LIN | Linde | $456.24 | $426.24 | -6.58% | Buy |
| PRM | Perimeter Solutions, SA | $12.10 | $7.00 | -42.15% | Buy |